Cargando…

Current Expertise, Opinions, and Attitude toward TNF-⍺ Antagonist Biosimilars among Physicians: A Self-Administered Online Survey in Western Switzerland

Tumor necrosis factor-alpha (TNF-⍺) antagonists are biological drugs with multiple authorized biosimilars. Biosimilars are becoming critical to the financial sustainability of health systems. Recent studies emphasize that physicians’ knowledge regarding biosimilars has not yet progressed sufficientl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krstic, Marko, Devaud, Jean-Christophe, Sadeghipour, Farshid, Marti, Joachim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690245/ https://www.ncbi.nlm.nih.gov/pubmed/36360497 http://dx.doi.org/10.3390/healthcare10112152

Ejemplares similares

Exploring the Reasons Behind the Substantial Discontinuation Rate Among Patients Taking CT-P13 in a Large Tertiary Hospital in Western Switzerland: A Retrospective Cohort Study Using Routinely Collected Medical Data
por: Krstic, Marko, et al.
Publicado: (2022)

Physicians’ Opinion Regarding Extended Access to Hormonal Contraception in Switzerland
por: Yous, Tamara, et al.
Publicado: (2021)

Navigating adalimumab biosimilars: an expert opinion
por: Abitbol, Vered, et al.
Publicado: (2023)

Apoptosis and the FLIP and NF-kappa B proteins as pharmacodynamic criteria for biosimilar TNF-alpha antagonists
por: Urbano, Paulo César Martins, et al.
Publicado: (2014)

Comparison of Uptake and Prices of Biosimilars in the US, Germany, and Switzerland
por: Carl, David L., et al.
Publicado: (2022)

Association of Generic Competition With Price Decreases in Physician-Administered Drugs and Estimated Price Decreases for Biosimilar Competition
por: Dickson, Sean R., et al.
Publicado: (2021)

Physicians in the Era of Automation: The Case for Clinical Expertise
por: Chartash, David, et al.
Publicado: (2019)

Juvenile dermatomyositis in Western Switzerland
por: Enders, F Bellutti, et al.
Publicado: (2011)

Effectiveness and safety of a biosimilar-to-biosimilar switch of the TNF inhibitor etanercept in patients with chronic inflammatory rheumatic diseases
por: Kiltz, Uta, et al.
Publicado: (2022)

The Role of Biosimilars in Uveitis: Long-Term Real-World Outcomes of the Switch From Original to Biosimilar TNF-Alpha Inhibitors
por: Fabiani, Claudia, et al.
Publicado: (2019)

Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians
por: Cohen, Hillel, et al.
Publicado: (2016)

Physicians’ perceptions of the uptake of biosimilars: a systematic review
por: Sarnola, Kati, et al.
Publicado: (2020)

Patients Retransitioning from Biosimilar TNFα Inhibitor to the Corresponding Originator After Initial Transitioning to the Biosimilar: A Systematic Review
por: Meijboom, Rosanne W., et al.
Publicado: (2021)

Patient-Physicians: Identities and Expertise Brought Into the Light of Diagnosis and Treatment
por: Arroyave, Carlos Andrés, et al.
Publicado: (2019)

Effective use of TNF antagonists
por: Yocum, David
Publicado: (2004)

Comparison of BRICS-TM Countries' Biosimilar Regulatory Frameworks With Australia, Canada and Switzerland: Benchmarking Best Practices
por: Rahalkar, Hasumati, et al.
Publicado: (2021)

Factors for starting biosimilar TNF inhibitors in patients with rheumatic diseases in the real world
por: Sung, Yoon-Kyoung, et al.
Publicado: (2020)

Key concepts in biosimilar medicines: What physicians must know
por: Iskit, Alper B.
Publicado: (2022)

Safety of Insulin Lispro and a Biosimilar Insulin Lispro When Administered Through an Insulin Pump
por: Thrasher, James, et al.
Publicado: (2018)

Expert opinion on livestock antimicrobial usage indications and patterns in Denmark, Portugal and Switzerland
por: Carmo, Luís Pedro, et al.
Publicado: (2018)

Outcomes following biosimilar TNF inhibitor use for inflammatory-mediated immune disorders in pregnancy
por: Scott, R, et al.
Publicado: (2021)

A qualitative evaluation of pharmacy technician opinions about administering immunizations
por: McKeirnan, Kimberly C., et al.
Publicado: (2023)

Comparative pharmacokinetics of an adalimumab biosimilar SB5 administered via autoinjector or prefilled syringe in healthy subjects
por: Shin, Donghoon, et al.
Publicado: (2018)

Physician, Practice, and Patient Characteristics Associated With Biosimilar Use in Medicare Recipients
por: Dean, Emma Boswell, et al.
Publicado: (2021)

Physicians’ Self-Conceptions of Their Expertise in Statutory Health Insurance and Social Security Systems
por: Seger, Wolfgang, et al.
Publicado: (2015)

The Physician's Holiday; or, a Month in Switzerland in the Summer of 1848
Publicado: (1852)

Biosimilar Use in Breast Cancer Treatment: A National Survey of Brazilian Oncologists' Opinions, Practices, and Concerns
por: Resende, Heloísa M., et al.
Publicado: (2021)

The Comparative Safety and Effectiveness of TNF-alpha Antagonists
por: Solomon, Daniel H.
Publicado: (2007)

An exploration of biosimilar TNF-alpha inhibitors uptake determinants in hospital environments in Italy, Portugal, and Spain
por: Barcina Lacosta, Teresa, et al.
Publicado: (2023)

Evaluation of Physicians’ Knowledge and Attitudes Towards Biosimilars in Russia and Issues Associated with Their Prescribing
por: Karateev, Dmitry, et al.
Publicado: (2019)

Physician-Level Cost Control Measures and Regional Variation of Biosimilar Utilization in Germany
por: Blankart, Katharina E., et al.
Publicado: (2020)

Cognitive perspectives on maintaining physicians’ medical expertise: III. Strengths and weaknesses of self-assessment
por: Fraundorf, Scott H., et al.
Publicado: (2023)

Physicians’ and patients’ opinions on the use of generic drugs
por: Sicras-Mainar, Antoni, et al.
Publicado: (2012)

Italian Physicians’ Opinions on Rotavirus Vaccine Implementation
por: Mita, Valentin, et al.
Publicado: (2017)

Radiology report: what is the opinion of the referring physician?
por: Ignácio, Fernando de Castro Guimarães Rios, et al.
Publicado: (2018)

Clinical Ethics Consultations in the Opinion of Polish Physicians
por: Czarkowski, Marek, et al.
Publicado: (2021)

Biosimilars
por: Martin, Miguel
Publicado: (2018)

A Physician's Holiday; or a Month in Switzerland in the Summer of 1848
Publicado: (1849)

A Physician's Holiday, or a Month in Switzerland in the Summer of 1848
Publicado: (1850)

Expertise and Technology
por: Hoc, Jean-Michel
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_s7s6db49pjhginkhq5usjelj04